Abstract

SOUSA, Círia Leandra Martins de et al. The Role of Enterolysis and Tamoxifen in Encapsulating Peritoneal Sclerosis: A Successful Case. Port J Nephrol Hypert [online]. 2022, vol.36, n.3, pp.180-184.  Epub Sep 30, 2022. ISSN 0872-0169.  https://doi.org/10.32932/pjnh.2022.08.194.

Encapsulating peritoneal sclerosis (EPS) is a rare complication of peritoneal dialysis which mortality can reach 50%. The usual treatment involves suspension of the technique, medical treatment, and surgical enterolysis.

We report the case of a 36-year-old female who undergone continuous ambulatory peritoneal dialysis without complications for 10 years. She presented at the emergency department with abdominal pain and a diagnosis of peritonitis was assumed. The patient developed a systemic inflammatory response, and her abdominal computer tomography (CT) scan showed multiple parietal calcifications. After multiple broad-spectrum antibiotics, an undetermined febrile syndrome persisted, and parenteral nutrition was started. An EPS diagnosis was established and treatment with tamoxifen was proposed. Exploratory laparoscopy was decided, and the intraoperative findings were consistent with EPS.

The patient was submitted to extensive enterolysis. A clinical improvement led to a discharge after 60 days of hospitalization. After more than 30 months with tamoxifen, she remains on hemodialysis and doing well. There are no randomized controlled trials to guide EPS management and the following procedures are more difficult to decide, who makes these reports important to the reflection. We describe a case of successful treatment of EPS, with a very severe presentation. The management with enterolysis and tamoxifen contributed decisively to this outcome.

Keywords : Peritoneal Dialysis/adverse effects; Peritoneal Fibrosis/diagnosis; Peritoneal Fibrosis/etiology; Peritoneal Fibrosis/surgery; Peritoneal Fibrosis/therapy; Tamoxifen/therapeutic use.

        · text in English     · English ( pdf )